CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, July 29th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...